Materials & Resources » Chemicals | Capro Corp.

Capro Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
116,360
101,988
7,720
9,977
16,850
13,773
Depreciation, Depletion & Amortization
28,364
29,245
29,314
26,773
26,449
25,514
Other Funds
12,028
829
41,209
3,835
5,354
211
Funds from Operations
75,967
73,572
19,615
12,961
48,653
39,498
Changes in Working Capital
22,031
39,078
16,017
70,028
235
30,730
Net Operating Cash Flow
53,936
34,493
3,598
57,067
48,888
8,769
Capital Expenditures
12,407
3,515
838
1,178
7,654
Sale of Fixed Assets & Businesses
-
21
23
18,075
39
Purchase/Sale of Investments
43,847
10,977
22,310
2,644
23,258
Net Investing Cash Flow
31,453
7,765
21,566
14,650
15,027
Cash Dividends Paid - Total
10,001
-
-
9
-
Issuance/Reduction of Debt, Net
77,500
8,000
39,500
23,047
37,886
Net Financing Cash Flow
67,499
8,000
39,500
23,038
37,886
Net Change in Cash
45,019
34,724
21,532
19,379
25,940
Free Cash Flow
66,343
38,009
4,435
58,245
41,234
Other Sources
158
357
70
5,019
35
Exchange Rate Effect
-
3
5
-
89
Other Uses
145
75
-
4,622
651

About Capro

View Profile
Address
14/F, Neewei Building
Seoul SL 04539
Korea, Republic Of
Employees -
Website http://www.hcccapro.co.kr
Updated 07/08/2019
Capro Corp. engages in the manufacture and sale of caprolactam and ammonium sulfate. Its products include Caprolactam, ammonlum sulphate, ammonlum sulphate nitrate, and methylethylketoxime. The company was founded on December 30, 1969 and is headquartered in Seoul, South Korea.